MVM Inc.

United States : BioVex Raises $30 Million.
TendersInfo; 11/11/2009; 753 words; Byline: manish03 BioVex Inc., a Woburn, Mass.-based...Morningside Venture, Ventech and MVM Life Science Partners co-led...around $180 million. BioVex Inc, a company developing new generation...Morningside Venture, Ventech and MVM Life Science Partners who were...

BioVex Completes $70 Million Financing to Conclude Pivotal Study With Its Pioneering Cancer Treatment, OncoVEX (GM-CSF).
PR Newswire; 11/10/2009; 1513 words; ...10 /PRNewswire/ -- BioVex Inc, a company developing new generation...Morningside Venture, Ventech and MVM Life Science Partners who were...Ventech and Steve Reeders of MVM Life Science Partners will join...States," said Steve Reeders of MVM Life Science Partners. "Given...

BioVex raises additional $30m ; Woburn firm tries new way to battle cancer
The Boston Globe; 11/10/2009; 720 words; BioVex Inc., a Woburn biotechnology company that raised...by a pair of Boston venture capital firms, MVM Life Science Partners and Morningside Venture...head and neck cancer. Steve Reeders, the MVM Life Science managing partner who will join...

Unigene Announces Financial Results for Third Quarter 2009.(Financial report)
Business Wire; 11/9/2009; 1996 words; ...BOONTON, N.J. -- Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene...Unigene received from Tarsa Therapeutics, Inc. ("Tarsa) on October 20, 2009 in association...funds specializing in the life sciences: MVM Life Science Partners, Quaker BioVentures...

Unigene Licenses Phase III Oral Calcitonin Program to Tarsa Therapeutics.
Women's Health Weekly; 11/5/2009; 1261 words; Unigene Laboratories, Inc. (OTCBB: UGNE) and Tarsa Therapeutics, Inc. announced that Unigene has...specializing in the life sciences: MVM Life Science Partners, Quaker...see also Unigene Laboratories, Inc. / Tarsa Therapeutics, Inc...